Natixis Investment Managers International’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,832
Closed -$524K 485
2022
Q1
$524K Buy
+3,832
New +$534K 0.01% 286
2018
Q4
Sell
-6,352
Closed -$685K 171
2018
Q3
$685K Sell
6,352
-1,704
-21% -$187K 0.03% 415
2018
Q2
$886K Buy
+8,056
New +$839K 0.05% 305
2017
Q4
Sell
-3,391
Closed -$318K 216
2017
Q3
$318K Sell
3,391
-188
-5% -$20K 0.03% 288
2017
Q2
$398K Buy
3,579
+3,079
+616% +$326K 0.03% 275
2017
Q1
$49K Hold
500
﹤0.01% 386
2016
Q4
$46K Buy
+500
New +$43.1K ﹤0.01% 414

Other funds holding DGX

Natixis Investment Managers International's DGX Position: Q2 2022 in Review

Natixis Investment Managers International sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 3,832 shares — an estimated $524K sold.

Natixis Investment Managers International first reported a position in DGX in Q4 2016 and held it in 7 quarters. The position peaked at $886K in Q2 2018. 852 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

  • Natixis Investment Managers International reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 3,832 Quest Diagnostics shares in Q2 2022, an estimated $524K.
  • Natixis Investment Managers International first reported a position in Quest Diagnostics in Q4 2016 and held it in 7 quarters.
  • Natixis Investment Managers International's Quest Diagnostics position peaked at $886K in Q2 2018.
  • 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on Natixis Investment Managers International's 13F filing for Q2 2022, filed 12 Aug 2022.